Suppressive chemoprophylaxis invites avoidable risk of serious illness caused by Plasmodium vivax malaria

Travel Medicine and Infectious Disease

Volumn 11, Issue 1, 2013, Pages 60-65

  Baird, J Kevin ^a,b  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Causal prophylaxis; Malaria; Plasmodium vivax; Primaquine

Indexed keywords

ATOVAQUONE PLUS PROGUANIL; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; PRIMAQUINE;

AFRICA; ARTICLE; CHEMOPROPHYLAXIS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EMPORIATRICS; ENDEMIC DISEASE; HUMAN; PLASMODIUM VIVAX MALARIA; PRIORITY JOURNAL; RISK ASSESSMENT;

ANTIMALARIALS; CHEMOPREVENTION; FEMALE; HUMANS; MALARIA, VIVAX; MALE; PLASMODIUM VIVAX; PREGNANCY; PRIMAQUINE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TRAVEL MEDICINE;

EID: 84875711736     PISSN: 14778939     EISSN: 18730442     Source Type: Journal    
DOI: 10.1016/j.tmaid.2013.01.002     Document Type: Article

References (35)

1. J.K. Baird Evidence and implications of mortality associated with acute Plasmodium vivax malaria Clin Rev Microbiol 26 1 2013 36 57
2. P. Gething, I.R.F. Elyazar, C.L. Moyes, D.L. Smith, K.E. Battle, and C.A. Guerra A long neglected world malaria map: Plasmodium vivax endemicity in 2010 PLoS Negl Trop Dis 6 2012 e1814
3. C.A. Guerra, R.E. Howes, A.P. Patil, P.W. Gething, T.P. Van Boeckel, and W.H. Temperley The international limits and population at risk of Plasmodium vivax transmission PLoS Negl Trop Dis 4 2010 e774
4. B.E. Gamma, M.V. Lacerda, C.T. Daniel-Ribero, and F. Ferreira-da-Cruz Chemoresistance of Plasmodium falciparum and Plasmodium vivax parasites in Brazil: consequences on disease morbidity and control Mem Inst Oswaldo Cruz 106 Suppl. 1 2011 159 166
5. J.K. Baird Resistance to therapies for infection by Plasmodium vivax Clin Microbiol Rev 22 2009 508 534
6. N.J. White Determinants of relapse periodicity in Plasmodium vivax malaria Malar J 10 2011 297
7. S.F. Kitchen Vivax malaria Chapter 43 M.F. Boyd, Malariology 1949 WB Saunders Company Philadelphia
8. K. Leder, J. Black, D. O'Brien, Z. Greenwood, K.C. Kain, and E. Schwartz Malaria in travelers: a review of the GeoSentinel surveillance network Clin Infect Dis 39 2004 1104 1112
9. R. Culleton, M. Ndounga, F.Y. Zeyrek, C. Coban, P.N. Casimiro, and S. Takeo Evidence for the transmission of Plasmodium vivax in the Republic of Congo, West Central Africa J Infect Dis 200 2009 1465 1469
10. G.K. John, N.M. Douglas, L. von Seidlein, F. Nosten, J.K. Baird, and N.J. White Primaquine radical cure of Plasmodium vivax: a critical review of the literature Malar J 11 2012 280
11. J.K. Baird Resistance to chloroquine unhinges vivax malaria therapeutics Antimicrob Agents Chemother 55 2011 1827 1830
12. J.K. Baird, J.D. Maguire, and R.N. Price Diagnosis and treatment of Plasmodium vivax malaria Chapter 4 S.I. Hay, The epidemiology of Plasmodium vivax: history, hiatus, and hubris D. Rollinson, Advances in Parasitology vol. 80 2012 201 268 Special issue A
13. I. Sutanto, B. Tjahjono, H. Basri, W.R. Taylor, F.A. Putri, and R.A. Meilia Randomized, open label trial of primaquine against vivax malaria relapse in Indonesia Antimicrob Agents Chemother 57 2013 1128 1135
14. E. Schwartz, and G. Regev-Yochay Primaquine as prophylaxis for malaria for nonimmune travelers: a comparision with mefloquine and doxycycline Clin Infect Dis 29 1999 1502 1506
15. E. Schwartz, M. Parise, P. Kozarsky, and M. Cetron Delayed onset of malaria-implications for chemoprophylaxis in travelers N Engl J Med 349 2003 1510 1516
16. P.M. Arguin, and S. Mali Malaria Chapter 3 Infectious diseases related to travel. The yellow book. US centers for disease control 2012 Georgia Atlanta
17. Treatment Guidelines Drugs for parasitic infections Med Lett Suppl. 8 2010 e1 e20
18. D.O. Freedman Malaria prevention in short-term travelers New Engl J Med 359 2008 603 612
19. P. Chiodini, D. Hill, D. Lalloo, G. Lea, E. Walker, and C. Whitty Guidelines for malaria prevention in travelers from the United Kingdom January 2007 Health Protection Agency London
20. S. Mali, S.P. Kachur, and P.M. Arguin Malaria surveillance - United States MMWR Surveill Summ 2012 61 2010 1 17
21. A.S. Alving, J. Arnold, R.S. Hockwald, C.B. Clayman, R.J. Dern, and E. Beutler Potentiation of the curative action of primaquine in vivax malaria by quinine and chloroquine J Lab Clin Med 46 1955 301 306
22. J.K. Baird, D.J. Fryauff, and S.L. Hoffman Primaquine for prevention of malaria in travelers Clin Infect Dis 37 2003 1659 1667
23. D.R. Hill, J.K. Baird, M.E. Parise, L.S. Lewis, E.T. Ryan, and A.J. Magill Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I Am J Trop Med Hyg 75 2006 402 415
24. D.J. Fryauff, J.K. Baird, H. Basri, I. Sumawinata, Purnomo, and T.L. Richie Randomized placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria Lancet 346 1995 1190 1193
25. J.K. Baird, M.D. Lacy, H. Basri, M.J. Barcus, J.D. Maguire, and M.J. Bangs Randomized, parallel placebo-controlled trial of primaquine for malaria prophylaxis in Papua, Indonesia Clin Infect Dis 33 2001 1990 1997
26. J.K. Baird, D.J. Fryauff, H. Basri, M.J. Bangs, B. Subianto, and I. Wiady Primaquine for prophylaxis against malaria among nonimmune transmigrants in Irian Jaya, Indonesia Am J Trop Med Hyg 52 1995 479 484
27. W.R. Weiss, A.J. Oloo, A. Johnson, D. Koech, and S.L. Hoffman Daily primaquine effective for prophylaxis against falciparum malaria in Kenya: comparison with mefloquine, doxycyline, and chloroquine plus proguanil J Infect Dis 171 1995 1678 1682
28. J. Soto, J. Toledo, M. Rodriguez, J. Sanchez, R. Herrera, and J. Padilla Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: efficacy and toxicity: a randomized, double-blind, placebo-controlled trial Ann Intern Med 129 1998 241 244
29. J.K. Baird Neglect of Plasmodium vivax malaria Trends Parasitol 23 2007 533 539
30. R.N. Price, E. Tjitra, C.A. Guerra, S. Yeung, N.J. White, and N.M. Anstey Vivax malaria: neglected and not benign Am J Trop Med Hyg 77 Suppl. 6 2007 79 87
31. J.D. Berman, R. Nielson, J.D. Chulay, M. Dowler, K.C. Kain, and K.E. Kester Causal prophylactic efficacy of atovaquone-proguanil (malarone) in human challenge model Trans Roy Soc Trop Med Hyg 95 2001 429 432
32. J.D. Maguire, and D.M. Llewellyn Relapsing vivax malaria after 6 months of daily atovaquone/proguanil in Afghanistan: the case for expanded use of primaquine as a causal prophylactic J Travel Med 14 2007 411 414
33. L. Povinelli, T.A. Monson, B.C. Fox, M.E. Parise, J.M. Morrisey, and A.B. Vaidya Plasmodium vivax malaria in spite of atovaquone/proguanil (Malarone) prophylaxis J Travel Med 10 2003 353 355
34. S. Gallien, F. Taieb, F. Schlemmer, M. Lagrange-Xelot, A. Atlan, and C. Sarfati Failure of atovaquone/proguanil to prevent Plasmodium ovale malaria in traveler returning from Cameroon Travel Med Infect Dis 6 2008 128 129
35. B.C. Jimenez, M. Navarro, H. Huerga, E. Lopez-Roman, A. Mendoza, and R. Lopez-Velez Tertian malaria (Plasmodium vivax and Plasmodium ovale) in two travelers despite atovaquone-proguanil prophylaxis J Travel Med 13 2008 2 7